the acute effects of oral hydralazine , 1 mg/kg , on coronary vascular resistance , coronary blood flow ( estimated using the coronary sinus thermodilution technique ) , and myocardial oxygen consumption were evaluated in 10 patients with chronic ( new york heart association class iii and iv ) nonischemic congestive heart failure .
C0020223
hydralazine
C0018802
congestive